Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
MRNA - Moderna, Inc.
Market Cap 42.02B P/E 9.48 EPS this Y 42.90% Ern Qtrly Grth -
Income -5.97B Forward P/E -27.08 EPS next Y 25.00% 50D Avg Chg -11.00%
Sales 5.15B PEG 0.37 EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 2.24 EPS next 5Y -51.34% 52W High Chg -49.00%
Recommedations 2.50 Quick Ratio 3.74 Shares Outstanding 383.24M 52W Low Chg -
Insider Own 9.59% ROA -15.72% Shares Float 346.12M Beta 1.57
Inst Own 73.07% ROE -37.68% Shares Shorted/Prior 21.07M/21.44M Price 110.22
Gross Margin -70.27% Profit Margin -115.82% Avg. Volume 3,254,514 Target Price 137.59
Oper. Margin -758.08% Earnings Date Aug 1 Volume 4,434,575 Change -3.26%
Healthcare | Biotechnology | United States
About Moderna, Inc.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna, Inc. News
05/17/24 Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
05/17/24 European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
05/17/24 Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
05/17/24 Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
05/17/24 The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
05/17/24 Could Novavax Become the Next Moderna?
05/16/24 Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
05/16/24 Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
05/14/24 Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
05/14/24 Is This a Setback for Moderna?
05/13/24 Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
05/13/24 While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
05/13/24 Company News For May 13, 2024
05/13/24 Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
05/13/24 Bull Market and Beyond: 2 Stocks Just Waiting to Soar
05/13/24 Moderna to Present at Upcoming Conferences in May/June 2024
05/12/24 Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
05/10/24 Novavax stock doubles after Sanofi deal marks 'new chapter' for company
05/10/24 Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
05/10/24 Consumer sentiment drops, Tesla's Supercharger, Zeekr IPO: Catalysts
MRNA Chatroom

User Image taxplanr Posted - 1 hour ago

ex CDC director calls for COVID jabs to be pulled from the market $MRNA $BNTX $PFE https://www.thegatewaypundit.com/2024/05/ex-cdc-director-admits-significant-side-effects-covid/?utm_source=rss&utm_medium=rss&utm_campaign=ex-cdc-director-admits-significant-side-effects-covid

User Image Outcomes Posted - 1 hour ago

$NRXP $PFE $MRNA $JNJ $AZN mRNA BAD. Beware Big pharma. Beware Bureaucrats. SS knows. JJ knows. Chaim knows. IIBR knows. MOH knows. Bibi knows. Viral Vector. Mucosal immunity....BriLife

User Image bearishbull710 Posted - 8 hours ago

$NVAX $MRNA $PFE $BNTX

User Image phoenixblaze Posted - 9 hours ago

$CYDY $PFE $MRNA https://x.com/SpartaJustice/status/1791244056778899605?t=cteviPdfG0o8iVYCjefLyw&s=08

User Image FrnkTss Posted - 12 hours ago

$MRNA 125 is now support, resist 135 https://youtu.be/n9Z4FQiK9oA

User Image Redneckmd Posted - 12 hours ago

@mikelman @Shortsales challenged and or delayed I think. $MRNA lawyers do not want him to testify- wonder why

User Image ShortyMcFly Posted - 18 hours ago

@SouthernItUp Damn, I knew it. Seemed so orchestrated front top down. Too many coincidences..🥼🚫🧫💉 $mrna $pfe $jnj $AZN $xbi etc #vaccines

User Image Wigglyick Posted - 19 hours ago

$MRNA should change its name to MacGyver. After hitting a low (last seen in 2020) it went onto double, all in a span of 7 months. Not bad ! I started a small position at 121ish. Good luck

User Image Fat_Finger Posted - 19 hours ago

$MRNA $PFE Prosecute/Fauci

User Image bearishbull710 Posted - 19 hours ago

$NVAX $MRNA $BNTX $PFE https://www.pbsnc.org/blogs/science/human-trials-start-this-year-on-dukes-combo-coronavirus-vaccine/

User Image Mervolo Posted - 20 hours ago

@Bernard_Madoff mmm i thnk the dollar was an important hold. it gave it cred. not gonna lie, shoulda prob sold above 3 but i ve been trail stopped out of one too many runners and if u can t handle a 2-3 buck swing then you re never gonna capture bigger gains. happened to me in $lcid under ten then it ran to over 30, $dwac at 13 then it ran to 175, $amc in 40s then ran to 60, $amtd maybe too at 4 then ran to 20s (i thnk that was the symbol but i just remeber i got in above 4, went to 3 or 2 something then mond it was 24). oh man and that s not even mentioning when we were trading $mrna! that spread was like 2-3 dollas alone i think. i guess my point is: if you re expecting ”dollar moves,” EXPECT dollar moves… in either direction. besides, i t hink someone else had already mentioned that like 85% of sales were short sales and that ladder attack on all runners in same theme at same time was NOT sus’ at all. so i don t think as many of us sold as they wanna make us think we did.

User Image NT22 Posted - 21 hours ago

$PFE just going to leave this here…. We all know that $MRNA did this…. People need to wake up and get pissed.

User Image NT22 Posted - 21 hours ago

@Texastrade @Offender totally normal. Nails $pfe and $MRNA

User Image DaveOOOOOH Posted - 23 hours ago

$MRNA It's unhealthy how much I don't like this company. Ironic?

User Image sanjay71 Posted - 1 day ago

$MRNA a total scam company, on record saying they made vaccine using software gene sequence. Software vaccine beat software virus. 😁

User Image goupdarnit Posted - 1 day ago

$MRNA this should go up Monday on the patent win seeing it went down over a loss on the less important patent

User Image Fat_Finger Posted - 1 day ago

$TSLA $MRNA $PFE Prosecute Fraudci

User Image Stocksrunner Posted - 1 day ago

Today's Unusual Options Activity Recap 📈 $BKNG Deep-pocketed investors are showing significant interest in Booking Holdings. $CVNA Analysis of options activity indicates cautious market sentiment with 36% of traders showing bearish tendencies. $MRNA Noteworthy Moves in Moderna Options Investors with substantial capital are favoring a bullish outlook on Moderna. $NVO A significant 78% of traders are favoring bullish positions based on recent options data. $VKTX Witnessing notable options activity, with 45% of traders showing bullish sentiment. Stay informed and consider these insights as you navigate the market. 🚀 https://stocksrunner.com/unusual

User Image STOCKPICKERTRADER Posted - 1 day ago

$PFE that $MRNA patent ruling will put some selling pressure on the shares for a bit I reckon - again

User Image goupdarnit Posted - 1 day ago

$MRNA it's obvious something is trying to keep this red

User Image cubz811 Posted - 1 day ago

$MRNA I don’t follow a 50 billion market cap for a company with an mrna Covid vax no one wants and no other proven products. Seems off

User Image DonCorleone77 Posted - 1 day ago

$MRNA $PFE $BNTX Moderna wins European patent case in Pfizer, BioNTech dispute, FT reports Moderna (MRNA) has won a case against Pfizer (PFE) and BioNTech (BNTX) at the European Patent Office in its ongoing legal dispute to recoup pandemic profits, The Financial Times' Oliver Barnes and Ian Johnston reports. The EPO's Opposition Division ruled to uphold the validity of one of two disputed patents, according to the report. "We are pleased to announce that the European Patent Office decided to maintain the validity of Moderna's EP949 patent, one of the key patents currently asserted against Pfizer and BioNTech in various European national courts," Moderna told the publication, which notes that Pfizer has a nine-month window to lodge an appeal, which it said it may do.

User Image BPID Posted - 1 day ago

$MRNA Run for cover shorts!

User Image RedStar_Empire Posted - 1 day ago

$MRNA ahhh shit👀👀👀

User Image Megalodon Posted - 1 day ago

$NVAX When I think of how paltry mRNA 'durability' is compared to NVAX adjuvanted protein subunit, I get excited about the prospects for taking away a huge chunk of $MRNA and PFE BNTX business with the marketing muscle of Sanofi.

User Image onisf1 Posted - 2 days ago

@OldFngGuy I’m not yet at your level, I do covered calls on my holdings to make some money, not that easy, I get killed sometimes ( like $MRNA) but it’s been profitable for a year and a half

User Image taxplanr Posted - 2 days ago

Surely this can't be happening with $MRNA $BNTX $PFE jabs https://dailysceptic.org/2024/05/15/cochrane-founder-peter-gotzsche-healthcare-is-much-more-corrupt-than-people-think/

User Image taxplanr Posted - 2 days ago

Jab linked to abdominal blood clotting $MRNA $BNTX $PFE https://www.infowars.com/posts/covid-vaccines-linked-to-rare-type-of-deadly-abdominal-blood-clots-study/

User Image vittoria64iez Posted - 2 days ago

$MRNA $WIMI Decisions need more time to understand

User Image MiaPatriot Posted - 2 days ago

$PFE $MRNA Wow! Would ya look at that? Another one of my conspiracy theories turned out to be conspiracy fact!!! AGAIN! I should sue jokebook and twatter for censoring the truth, AGAIN. https://nypost.com/2024/05/16/us-news/nih-director-admits-taxpayers-funded-gain-of-function-research-in-wuhan-four-years-after-covid-pandemic-began/

Analyst Ratings
Evercore ISI Group In-Line May 14, 24
UBS Buy May 7, 24
Canaccord Genuity Hold May 3, 24
RBC Capital Outperform May 3, 24
Oppenheimer Outperform May 3, 24
Needham Hold May 2, 24
Needham Hold Apr 11, 24
Jefferies Buy Apr 9, 24
RBC Capital Outperform Mar 28, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hoge Stephen President President Dec 27 Sell 100.01 45,000 4,500,450 1,531,063 12/28/23
Klinger Shannon Thyme Chief Legal Officer Chief Legal Officer Dec 07 Sell 79.09 563 44,528 7,912 12/11/23
AFEYAN NOUBAR Director Director Nov 01 Sell 75.73 10,000 757,300 2,146,931 11/03/23
AFEYAN NOUBAR Director Director Oct 25 Sell 77.49 10,000 774,900 2,156,931 10/27/23
AFEYAN NOUBAR Director Director Oct 11 Sell 104.26 15,000 1,563,900 2,166,931 10/13/23
Mock James M Chief Financial Offi.. Chief Financial Officer Oct 05 Sell 102.5 2,858 292,945 2,952 10/10/23
AFEYAN NOUBAR Director Director Oct 04 Sell 102.05 15,000 1,530,750 2,181,931 10/06/23
AFEYAN NOUBAR Director Director Sep 27 Sell 99.37 10,000 993,700 2,196,931 09/29/23
AFEYAN NOUBAR Director Director Sep 20 Sell 104.9 15,000 1,573,500 2,206,931 09/22/23
AFEYAN NOUBAR Director Director Sep 13 Sell 111.17 15,000 1,667,550 2,221,931 09/15/23
AFEYAN NOUBAR Director Director Sep 06 Sell 108.08 15,000 1,621,200 1,982,209 09/08/23
Garay Arpa Chief Commercial Off.. Chief Commercial Officer Sep 05 Sell 108.4 574 62,222 3,113 09/07/23
AFEYAN NOUBAR Director Director Aug 30 Sell 115.96 15,000 1,739,400 1,997,209 09/01/23
AFEYAN NOUBAR Director Director Aug 23 Sell 114.78 15,000 1,721,700 2,012,209 08/25/23
AFEYAN NOUBAR Director Director Aug 16 Sell 97.71 10,000 977,100 2,027,209 08/18/23
Hoge Stephen President President Aug 17 Sell 100.00 15,000 1,500,000 1,587,579 08/18/23
AFEYAN NOUBAR Director Director Aug 02 Sell 112.08 15,000 1,681,200 2,037,209 08/04/23
AFEYAN NOUBAR Director Director Jul 26 Sell 120.47 15,000 1,807,050 2,052,209 07/28/23
AFEYAN NOUBAR Director Director Jul 19 Sell 125.16 15,000 1,877,400 2,067,209 07/21/23
AFEYAN NOUBAR Director Director Jul 12 Sell 125.9 15,000 1,888,500 2,082,209 07/14/23
AFEYAN NOUBAR Director Director Jul 05 Sell 125.84 15,000 1,887,600 2,097,209 07/07/23
AFEYAN NOUBAR Director Director Jun 28 Sell 121.33 15,000 1,819,950 2,112,209 06/30/23
AFEYAN NOUBAR Director Director Jun 21 Sell 122.45 15,000 1,836,750 2,127,209 06/23/23
AFEYAN NOUBAR Director Director Jun 14 Sell 126.73 15,000 1,900,950 2,142,209 06/16/23
AFEYAN NOUBAR Director Director Jun 07 Sell 126.17 15,000 1,892,550 2,157,209 06/09/23
Garay Arpa Chief Commercial Off.. Chief Commercial Officer Jun 05 Sell 125.75 2,290 287,968 2,547 06/07/23
AFEYAN NOUBAR Director Director May 31 Sell 127.7 15,000 1,915,500 2,172,209 06/02/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 26 Sell 131.62 80,000 10,529,600 5,411,946 04/28/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 26 Option 0.99 80,000 79,200 5,451,946 04/28/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 19 Sell 142.81 80,000 11,424,800 5,411,946 04/21/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 19 Option 0.99 80,000 79,200 5,451,946 04/21/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 05 Sell 155.78 80,000 12,462,400 5,411,946 04/07/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 05 Option 0.99 80,000 79,200 5,451,946 04/07/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Mar 22 Sell 150.21 80,000 12,016,800 5,411,946 03/24/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Mar 22 Option 0.99 80,000 79,200 5,451,946 03/24/23
AFEYAN NOUBAR Director Director Mar 01 Sell 139 10,000 1,390,000 2,187,209 03/03/23
Hoge Stephen President President Feb 28 Sell 138.03 1,072 147,968 1,629,031 03/02/23
Hoge Stephen President President Feb 28 Option 0 2,410 1,630,103 03/02/23
AFEYAN NOUBAR Director Director Feb 15 Sell 173.17 10,000 1,731,700 2,207,209 02/17/23
Hoge Stephen President President Feb 09 Sell 163.9 245 40,156 1,627,693 02/13/23
Hoge Stephen President President Feb 09 Option 0 522 1,627,938 02/13/23
AFEYAN NOUBAR Director Director Feb 08 Sell 166.92 20,000 3,338,400 2,217,209 02/10/23
AFEYAN NOUBAR Director Director Jan 25 Sell 194.33 10,000 1,943,300 2,237,209 01/27/23
AFEYAN NOUBAR Director Director Jan 18 Sell 200.20 10,000 2,002,000 2,247,209 01/20/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 18 Sell 198.64 80,000 15,891,200 5,411,946 01/20/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 18 Option 0.99 80,000 79,200 5,451,946 01/20/23
AFEYAN NOUBAR Director Director Jan 11 Sell 188.57 10,000 1,885,700 2,257,209 01/13/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 184.24 80,000 14,739,200 5,411,946 01/13/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 11 Option 0.99 80,000 79,200 5,451,946 01/13/23
AFEYAN NOUBAR Director Director Jan 04 Sell 182.15 10,000 1,821,500 2,267,209 01/06/23